je.st
news
Tag: alexion
X-Chem Announces Achievement Of Milestone In Alexion Collaboration
2016-05-03 03:14:35| drugdiscoveryonline News Articles
X-Chem, Inc. (X-Chem), a privately held biotechnology company utilizing its industry-leading DNA-Encoded X-Chem (DEX) drug discovery platform for the identification of first-in-class small molecule therapeutics, recently announced that it has achieved a milestone in its drug discovery collaboration with Alexion Pharmaceuticals, Inc., triggering a payment to X-Chem
Tags: collaboration
achievement
announces
milestone
Magee Thomson Investment Partners LLC Has $8,800,000 Stake in Alexion Pharmaceuticals, Inc.
2016-02-20 02:52:10| Biotech - Topix.net
Magee Thomson Investment Partners LLC boosted its position in Alexion Pharmaceuticals, Inc. by 1.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,130 shares of the biopharmaceutical company's stock after buying an additional 540 shares during the period.
Tags: inc
partners
llc
investment
UPDATE 1-UK cost agency queries value of $700,000-a-year Alexion drug
2016-02-18 12:56:58| Biotech - Topix.net
An enzyme treatment from Alexion Pharmaceuticals costing 491,992 pounds a year may be worth using in babies with a rare disorder but does not represent good value for all patients, Britain's healthcare cost watchdog said. Kanuma is designed for treating lysosomal acid lipase deficiency, a rare inherited genetic disease in which fats build up in cells.
Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management
2016-01-11 06:07:38| Biotech - Topix.net
EQIS Capital Management decreased its stake in Alexion Pharmaceuticals, Inc. by 51.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 9,974 shares of the biopharmaceutical company's stock after selling 10,740 shares during the period.
Tags: management
position
capital
decreased
Weekly CFO Sales Highlight: H&R Block, DISH Network, Alexion Pharmaceuticals
2016-01-04 07:55:01| Telecom - Topix.net
According to GuruFocus Insider Data, the recent CFO sales were: H&R Block Inc. , DISH Network Corp. , and Alexion Pharmaceuticals Inc. . On Dec. 29, Macfarlane sold 265,778 shares at an average price of $33.51.
Tags: sales
network
block
weekly